For ovarian cancer, inhibiting the SHH signaling pathway by cyclopamine (Cyp), an inhibitor of the SHH pathway, resulted in the reduction of ovarian cancer cell viability, as well as arresting the tumor growth in vivo.15 This evidence concerns the gene SHH and ovarian cancer.